Skip to main content
. 2003 Mar 18;88(6):814–821. doi: 10.1038/sj.bjc.6600794

Table 5. Total plasma clearance (CL) of unbound platinum (Pt), urinary excretion (0–24 h after start of infusion), renal clearance, and terminal half-life (t1/2) of Pt in plasma during course one.

  CL unbound Pt (ml min−1) Urinary Pt excretion (% dose) Renal CL Pt (ml min−1) t1/2 (h)
Mean 583 29 163 0.47
s.d. 152 6 36 0.16
Range 381–1223 11–38 87–262 0.31–1.06
N 76 69 69 76